Baidu
map

血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2018 奥地利建议：真性红细胞增多症的管理

2018-07-19 国外血液科相关专家小组 Wien Klin Wochenschr. 2018 Jul 19.

真性红细胞增多症

真性红细胞增多症（PV）是一种造血干细胞的克隆性慢性骨髓增殖性疾病。PV患者主要治疗目标是预防静脉血栓栓塞事件，预防疾病转化。本文主要介绍了PV的流行病学，病理和分子遗传学，临床表现，诊断，预后和治疗。

中文标题：

2018 奥地利建议：真性红细胞增多症的管理

英文标题：

Austrian recommendations for the management of polycythemia vera.

发布机构：

国外血液科相关专家小组

发布日期：

2018-07-19

简要介绍：

真性红细胞增多症（PV）是一种造血干细胞的克隆性慢性骨髓增殖性疾病。PV患者主要治疗目标是预防静脉血栓栓塞事件，预防疾病转化。本文主要介绍了PV的流行病学，病理和分子遗传学，临床表现，诊断，预后和治疗。 

拓展指南：与真性红细胞增多症相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 奥地利建议：真性红细胞增多症的管理)] GetToolGuiderByIdResponse(projectId=1, id=770ca1c00161914d, title=2018 奥地利建议：真性红细胞增多症的管理, enTitle=Austrian recommendations for the management of polycythemia vera., guiderFrom=Wien Klin Wochenschr. 2018 Jul 19., authorId=null, author=, summary=真性红细胞增多症（PV）是一种造血干细胞的克隆性慢性骨髓增殖性疾病。PV患者主要治疗目标是预防静脉血栓栓塞事件，预防疾病转化。本文主要介绍了PV的流行病学，病理和分子遗传学，临床表现，诊断，预后和治疗。 , cover=, journalId=null, articlesId=null, associationId=971, associationName=国外血液科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jul 19 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>真性红细胞增多症（PV）是一种造血干细胞的克隆性慢性骨髓增殖性疾病。PV患者主要治疗目标是预防静脉血栓栓塞事件，预防疾病转化。本文主要介绍了PV的流行病学，病理和分子遗传学，临床表现，诊断，预后和治疗。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>真性红细胞增多症</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=93e431c00161106d" title="2018 SIE共识建议：放血疗法治疗真性红细胞增多症" target=_blank>2018 SIE共识建议：放血疗法治疗真性红细胞增多症</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=110171c0011e8aa7" title="真性红细胞增多症诊断与治疗中国专家共识（2016年版）" target=_blank>真性红细胞增多症诊断与治疗中国专家共识（2016年版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E7%9C%9F%E6%80%A7%E7%BA%A2%E7%BB%86%E8%83%9E%E5%A2%9E%E5%A4%9A%E7%97%87" target=_blank>有关真性红细胞增多症更多指南</a></ul>, tagList=[TagDto(tagId=34446, tagName=真性红细胞增多症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4642, appHits=128, showAppHits=4, pcHits=2935, showPcHits=2346, likes=104, shares=2, comments=3, approvalStatus=1, publishedTime=Mon Jul 23 21:27:38 CST 2018, publishedTimeString=2018-07-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 23 21:27:38 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:55:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 奥地利建议：真性红细胞增多症的管理)])
2018 奥地利建议：真性红细胞增多症的管理
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220405, encodeId=75b11220405ea, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72649, encryptionId=8012e2649f1, topicName=真性红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:40:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333696, encodeId=29533336968c, content=刚好遇到一个病人, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:00:45 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333693, encodeId=e6963336931d, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 23 22:57:31 CST 2018, time=2018-07-23, status=1, ipAttribution=)]
    2022-05-17 赛华佗

    #真性红细胞增多症#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220405, encodeId=75b11220405ea, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72649, encryptionId=8012e2649f1, topicName=真性红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:40:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333696, encodeId=29533336968c, content=刚好遇到一个病人, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:00:45 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333693, encodeId=e6963336931d, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 23 22:57:31 CST 2018, time=2018-07-23, status=1, ipAttribution=)]
    2018-07-23 12355bb4m53(暂无昵称)

    刚好遇到一个病人

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220405, encodeId=75b11220405ea, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72649, encryptionId=8012e2649f1, topicName=真性红细胞增多症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:40:15 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333696, encodeId=29533336968c, content=刚好遇到一个病人, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=981b2401455, createdName=12355bb4m53(暂无昵称), createdTime=Mon Jul 23 23:00:45 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333693, encodeId=e6963336931d, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jul 23 22:57:31 CST 2018, time=2018-07-23, status=1, ipAttribution=)]
    2018-07-23 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

相关指南

2018 SIE共识建议：放血疗法治疗真性红细胞增多症

意大利血液学和肿瘤学协会(AIEOP,Associazione Italiana Ematologia Oncologia Pediatrica) · 2018-06-28

真性红细胞增多症诊断与治疗中国专家共识（2016年版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2016-04-27

Baidu
map
Baidu
map
Baidu
map